Corporate Actions

Back

Sun Pharma's ratings reaffirmed by CRISIL, India Ratings, and CARE, covering INR 30,000 crore

13-Oct-26 18:32 Hrs IST

Sun Pharmaceutical Industries Ltd announced today that CRISIL Ratings has reaffirmed its ratings on the company, including the long-term rating of "CRISIL AAA/Stable" and the short-term rating of "CRISIL A1+," while simultaneously withdrawing the ratings as they are no longer required by the rated entity; India Ratings & Research (Ind-Ra) has also reaffirmed its ratings, assigning a long-term rating of "IND AAA (Stable)" and a short-term rating of "IND A1+"; furthermore, CARE Ratings has reaffirmed its ratings, maintaining a long-term rating of "CRISIL AAA (Stable)" and a short-term rating of "CRISIL A1+," with a standalone credit watch positive; these ratings cover bank loan facilities aggregating to INR 27,000 crore, commercial paper of INR 2,000 crore, and preference shares amounting to INR 1,000 crore, with the reaffirmations reflecting Sun Pharma’s strong financial risk profile and market position, and the withdrawals by CRISIL are solely due to the company’s request.

Attention Investors:

Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020. || Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge. || Pay 20% upfront margin of the transaction value to trade in cash market segment. || Investors may please refer to the Exchange's Frequently Asked Questions (FAQs) issued vide circular reference NSE/INSP/45191 dated July 31, 2020 and NSE/INSP/45534 dated August 31, 2020 and other guidelines issued from time to time in this regard. || Check your Securities /MF/ Bonds in the consolidated account statement issued by NSDL/CDSL every month. || KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary. || No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.